Literature DB >> 2055300

Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis.

M C Bonaldo1, L N d'Escoffier, J M Salles, S Goldenberg.   

Abstract

Investigation of protease activities during the transformation of Trypanosoma cruzi epimastigotes into metacyclic trypomastigoes (metacyclo-genesis) revealed three major components with apparent molecular weights of 65, 52, and 40 kDa. The 65-kDa protease is a metacyclic trypomastigote stage-specific protease with an isoelectric point of 5.2 whose activity is inhibited by 1,10-phenanthroline, suggesting that it might be a metalloprotease. The 52-kDa component is also a metalloprotease which is constitutively expressed in epimastigotes and metacyclic trypomastigoes. On the other hand, the 40-kDa component is apparently made up of several isoforms of a cysteine protease which is expressed in much higher levels in epimastigotes than in metacyclic trypomastigote forms. The fact that the 65- and 40-kDa proteases are developmentally regulated suggests that proteases might be important for T. cruzi differentiation. Accordingly, T. cruzi metacyclogenesis is blocked by metallo- and cysteine-protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055300     DOI: 10.1016/0014-4894(91)90006-i

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  15 in total

1.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Gp63-like molecules in Phytomonas serpens: possible role in the insect interaction.

Authors:  Claudia M d'Avila-Levy; Lívia O Santos; Fernanda A Marinho; Felipe A Dias; Angela H Lopes; André L S Santos; Marta H Branquinha
Journal:  Curr Microbiol       Date:  2006-05-09       Impact factor: 2.188

3.  Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.

Authors:  C Serveau; G Lalmanach; M A Juliano; J Scharfstein; L Juliano; F Gauthier
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

4.  Identification and characterization of cysteine proteinases of Trypanosoma evansi.

Authors:  S C Yadav; R Kumar; S Kumar; U Tatu; R K Singh; A K Gupta
Journal:  Parasitol Res       Date:  2011-02-25       Impact factor: 2.289

5.  Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba.

Authors:  N A Khan; E L Jarroll; N Panjwani; Z Cao; T A Paget
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Differentiation of Trypanosoma cruzi I (TcI) and T. cruzi II (TcII) genotypes using genes encoding serine carboxypeptidases.

Authors:  Catarina Andréa Chaves de Araújo; Christoph Mayer; Peter Josef Waniek; Patricia Azambuja; Ana Maria Jansen
Journal:  Parasitol Res       Date:  2016-07-28       Impact factor: 2.289

7.  The use of an excreted superoxide dismutase in an ELISA and Western blotting for the diagnosis of Leishmania (Leishmania) infantum naturally infected dogs.

Authors:  C Marín; S S Longoni; H Mateo; J A de Diego; J M Alunda; G Minaya; M Sánchez-Moreno
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

8.  gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

Authors:  Ileana C Cuevas; Juan J Cazzulo; Daniel O Sánchez
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Further characterization of Trypanosoma cruzi GP57/51 as the major antigen expressed by differentiating epimastigotes.

Authors:  M C Bonaldo; J Scharfstein; A C Murta; S Goldenberg
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

10.  Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation.

Authors:  N Plasman; J G Guillet; B Vray
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.